On Invalid Date, Centessa Pharmaceuticals (NASDAQ: CNTA) reported Q4 2023 earnings per share (EPS) of -$0.37, up 17.78% year over year. Total Centessa Pharmaceuticals earnings for the quarter were -$36.84 million. In the same quarter last year, Centessa Pharmaceuticals's earnings per share (EPS) was -$0.45.
As of Q2 2024, Centessa Pharmaceuticals's earnings has grown year over year. Centessa Pharmaceuticals's earnings in the past year totalled -$151.09 million.
What is CNTA's earnings date?
Centessa Pharmaceuticals's earnings date is Invalid Date. Add CNTA to your watchlist to be reminded of CNTA's next earnings announcement.
What was CNTA's revenue last quarter?
On Invalid Date, Centessa Pharmaceuticals (NASDAQ: CNTA) reported Q4 2023 revenue of $6.85 million up Infinity% year over year. In the same quarter last year, Centessa Pharmaceuticals's revenue was $0.00.
What was CNTA's revenue growth in the past year?
As of Q2 2024, Centessa Pharmaceuticals's revenue has grown null year over year. Centessa Pharmaceuticals's revenue in the past year totalled $6.85 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.